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The relationship between uncertainty tolerance and 
oncologists’ perceptions of large-panel genomic tumor testing
Eric Anderson1, Alexandra Hinton1, Christine Lary1, Kimberly Murray1, Leo Waterston1, Paul Han1
Maine Cancer Genomics Initiative*  
Introduction
Large-panel genomic tumor testing (GTT) is a new technology that promises to 
make cancer treatment more precise, but that currently poses many uncertainties 
regarding its clinical value and appropriate use. Uncertainty Tolerance (UT), a 
psychological construct that describes trait-level differences in individuals’ 
responses to uncertainty, may influence oncologists’ perceptions and attitudes 
regarding GTT.
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Methods
Sample. 57 Community-based oncologists participating in a statewide study 
of large-panel GTT in routine oncology care completed surveys assessing their 
perceptions and attitudes regarding GTT. 
Conclusions
• Oncologists’ perceived uncertainty about GTT is associated with their global 
attitudes towards GTT.  Higher uncertainty is associated with more negative 
attitudes.
• Moreover, this relationship is moderated by individual differences in oncologists’ 
uncertainty tolerance (UT).  Greater UT buffers the relationship between 
uncertainty and negative attitudes.  Furthermore, UT appears to have differential 
effects depending on the type of uncertainty (ambiguity, risk, complexity).
• More research is needed to understand the mechanisms by which UT influences 
perceptions, attitudes, and practices regarding GTT and other uncertain medical 
interventions.   
Perceived uncertainty about GTT (1-item): Genomic tumor testing seems uncertain
Attitudes about GTT (8-items, α = 0.67): GTT seems:
…beneficial 
…harmful *
…accurate 
…unproven *
…trustworthy, complicated, inefficient *, worthwhile
* reverse coded
Self-efficacy about GTT (4-items, α = 0.82): Confidence in: 
…ability to interpret results
…ability to explain results
…ability to make appropriate treatment decisions
…your practice’s ability to implement GTT
Ambiguity Tolerance (Han Ambiguity in Medicine Scale; Han et al., 2009)
I would not have confidence in a medical test or treatment if experts had conflicting opinions about it.
I would not be afraid of trying a medical test or treatment even if experts had conflicting opinions about it.
If experts had conflicting opinions about a medical test or treatment, I would still be willing to try it.
Risk Tolerance (Pearson Risk Attitude Scale; Pearson et al., 1995)
I try to avoid situations that have uncertain outcomes.
Taking risks does not bother me if the gains involved are high.
I rarely, if ever, take risks when there is another alternative.
Complexity Tolerance (Geller Tolerance for Ambiguity Scale; Geller et al., 1990)
If I am uncertain about the responsibilities involved in a particular task, I get very anxious.
I don’t like to work on a problem unless there is a possibility of getting a clear-cut and unambiguous answer.
A good task is one in which what is to be done and how it is to be done are always clear.
Study sample (N = 57)
Gender
Female 26 (46%)
Practice location
Rural 17 (30%)
Small town 15 (26%)
Suburban 12 (21%)
Urban 9 (16%)
Years of Experience
1-4 1 (1.9%)
5-9 7 (13%)
10-19 23 (43%)
20-29 13 (24%)
30+ 10 (19%)
Specialty 
Hematology/Oncology 47 (84%)
Surgery 4 (7.1%)
Gynecology 2 (3.6%)
Urology 1 (1.8%)
Neurology 1 (1.8%)
p=0.6
(β=0.05)
Perceived 
uncertainty about 
GTT
Self-efficacy about GTT
Attitudes about GTT
Complexity 
Tolerance  
(TFA)
Ambiguity 
Tolerance 
(AAMED)
Risk 
Tolerance 
(PRA)
p=0.25
(β=0.07
p=0.035 
(β=0.15)
p=0.057 
(β=0.13)
p=0.7 
(β=0.04) p=0.037
(β=0.23)
*
* β=-0.21; p<0.001
β=-0.11; p=0.24
*
Uncertainty Tolerance:
Association between perceived uncertainty and attitudes and self-efficacy
Moderating effect of uncertainty tolerance
Complexity Tolerance  (TFA)Ambiguity Tolerance (AAMED) Risk Tolerance (PRA)
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Perceived uncertainty 
about GTT
Negative
Positive
Extremely
confident
Not at all
confident
Certain Uncertain Certain Uncertain
High tolerance 
Low tolerance 
Notes: For this figure, participants median split 
by different types of uncertainty tolerance into 
high/low groups. 
* p = 0.035
* p = 0.037
Statistical Analysis. The relationship between perceived uncertainty and 
self-efficacy and attitudes regarding GTT was explored using GLMs. 
Oncologists’ UT was assessed as a moderator. 
Measures. 
Uncertainty Tolerance (UT). Separate subscales assessed tolerance of 3 types 
of uncertainty: ambiguity, risk, and complexity
Results
Sample Characteristics
